tility of autologous fibrin glue for prevention of delayed bleeding of gastric endoscopic submucosal dissection under antithrombotic therapy
Not Applicable
Recruiting
- Conditions
- Gastric neoplasms
- Registration Number
- JPRN-UMIN000019386
- Lead Sponsor
- Toranomon hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1. Hb<11g/dl 2. patients with active infections disease 3. patients under severe dehydration condition 4. patients with allergy for bovine product 5. patients taking antiplasmin agent 6. Patients were excluded if they were considered inappropriate for participation in this study by their attending physician.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method rate of delayed bleeding
- Secondary Outcome Measures
Name Time Method adverse event of autologous fibrin glue rate of allogeanic blood transfusion rate of autologous blood transfusion condition of ESD ulcer and fibrin glue on 1POD, 7POD, and 8 week.